drugset / Trial / NCT03923478
ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 1B randomized, double-blind, placebo-controlled, two-cohort clinical trial of ABI-M201 in adult subjects with mildly-to-moderately active Ulcerative Colitis(UC) and ongoing treatment with mesalamine.
Timeline
- Start
- 2019-06-24
- Primary completion
- 2021-01-20
- Completion
- 2021-01-20
Outcome
Outcome not reported
Stopped (Business): “Sponsor Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABI-M201 | Unknown | — | Oral |